The expression of PLOD1 was an independent prognostic factor in BLCA patients, and downregulated by inhibitor could significantly reduce the invasiveness of BLCA cells (Yamada et al., 2019). The gene discussed is PLOD1; the disease is bladder transitional cell carcinoma.